Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems

被引:3
|
作者
Ben Slama, Sana [1 ]
Ben Ghachem, Dorra [2 ]
Dhaoui, Amen [2 ]
Jomni, Mohamed Taieb [3 ]
Dougui, Mohamed Hedi [3 ]
Bellil, Khadija [2 ]
机构
[1] Hop M Slim La Marsa, Serv Anat Pathol, 2046 Sidi Daoud, Tunis, Tunisia
[2] Hop FSI La Marsa, Serv Anat Pathol, La Marsa, Tunisia
[3] Hop FSI La Marsa, Serv Gastroenterol, La Marsa, Tunisia
来源
关键词
Chronic gastritis; helicobacter pylori; atrophic gastritis; intestinal metaplasia; staging;
D O I
10.11604/pamj.2016.23.28.8839
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Helicobacter pylori (H pylori) gastritis presents a risk of cancer related to atrophy and intestinal metaplasia. Two recent classifications OLGA (Operative Link on Gastritis Assessment) and OLGIM (Operative Link on Gastritic Intestinal Metaplasia assessment) have been proposed to identify high-risk forms (stages III and IV). The aim of this study is to evaluate the OLGA and OLGIM staging systems in H pylori gastritis. A descriptive study of 100 cases of chronic H pylori gastritis was performed. The revaluation of Sydney System parameters of atrophy and intestinal metaplasia, of gastric antrum and corpus, allowed identifying respectively the stages of OLGA and OLGIM systems. The progressive risk of our H pylori gastritis was 6% according to OLGA staging and 7% according to OLGIM staging. Significant correlation was revealed between age and OLGA staging. High-risk gastritis according to OLGIM staging was significantly associated with moderate to severe atrophy. High-risk forms according to OLGA staging were associated in 80% of the cases to intestinal metaplasia. OLGA and OLGIM systems showed a highly significant positive correlation between them with a mismatch at 5% for H pylori gastritis. The OLGA and OLGIM staging systems in addition to Sydney System, allow selection of high risk forms of chronic gastritis requiring accurate observation.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis
    ElZimaity, HMT
    Graham, DY
    AlAssi, MT
    Malaty, H
    Karttunen, TJ
    Graham, DP
    Huberman, RM
    Genta, RM
    HUMAN PATHOLOGY, 1996, 27 (01) : 35 - 41
  • [32] Interobserver variation in histoplathological assessment of Helicobacter pylori gastritis
    Aydin, O
    Egilmez, R
    Karabacak, T
    Kanik, A
    WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (10) : 2232 - 2235
  • [33] FICE Endoscopy Diagnostic Accuracy by Applying OLGA and OLGIM Systems
    Kikuste, Ilze
    Isajevs, Sergejs
    Liepniece-Karele, Inta
    Janciauskas, Dainius
    Tolmanis, Ivars
    Leja, Marcis
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB224 - AB224
  • [34] GASTRITIS OLGA STAGING AND GASTRIC CANCER SECONDARY PREVENTION
    Fassan, Matteo
    Meggio, Alberto
    Pennelli, Gianmaria
    Mescoli, Claudia
    Graham, David Y.
    Rugge, Massimo
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3277 - 3278
  • [35] Gastritis: Beyond Helicobacter pylori
    Lauwers, Gregory Y.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2010, 18 (03) : 28S - 32S
  • [36] Helicobacter pylori gastritis - Epidemiology
    Sipponen, P
    JOURNAL OF GASTROENTEROLOGY, 1997, 32 (02) : 273 - 277
  • [37] Gastrointestinal:: Helicobacter pylori gastritis
    Tam, W
    Roberts-Thomson, IC
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (06) : 677 - 677
  • [38] Helicobacter pylori and atrophic gastritis
    Kuipers, EJ
    Appelmelk, BJ
    BIOMEDICINE & PHARMACOTHERAPY, 1997, 51 (04) : 150 - 155
  • [39] Assessment of the usefulness of endoscopic signs in Helicobacter pylori associated gastritis
    Yela, MC
    Manzano, ML
    RodriguezMunoz, S
    Sanchez, F
    PerezCarreras, M
    SanchezPobre, P
    Garfia, C
    Castellano, G
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1997, 89 (01) : 8 - 12
  • [40] Helicobacter pylori gastritis—Epidemiology
    Pentti Sipponen
    Journal of Gastroenterology, 1997, 32 : 273 - 277